Patrick J. Christmas
General Counsel, K-V Pharmaceutical Co.
Companies
- REGENXBIO Inc.Chief Strategy & Legal Officer Aug 4, 2025 to now1
- REGENXBIO Inc.General counsel Aug 22, 2016 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- REGENXBIO Inc. RGNX205,968 shares3$1.5M at $7.17Aug 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 1, 2026Shares withheld for tax 4,699 shares at $9.69 of REGENXBIO Inc.3
- Feb 1, 2026Shares withheld for tax 4,700 shares at $11.16 of REGENXBIO Inc.4
- Jan 6, 2026Granted 73,749 shares of REGENXBIO Inc.5
- Jan 2, 2026Shares withheld for tax 9,793 shares at $14.40 of REGENXBIO Inc.6
- Aug 1, 2025Shares withheld for tax 4,699 shares at $8.19 of REGENXBIO Inc.7
- Feb 1, 2025Shares withheld for tax 4,700 shares at $8.07 of REGENXBIO Inc.8
- Jan 2, 2025Shares withheld for tax 11,395 shares at $7.73 of REGENXBIO Inc.9
- Aug 1, 2024Granted 56,446 shares of REGENXBIO Inc.10
- Jan 2, 2024Granted 34,615 shares of REGENXBIO Inc.11
- Jan 2, 2024Shares withheld for tax 7,893 shares at $17.95 of REGENXBIO Inc.11
- Jan 3, 2023Granted 67,940 shares of REGENXBIO Inc.12
- Jan 3, 2023Shares withheld for tax 1,843 shares at $22.68 of REGENXBIO Inc.12
- Jan 3, 2022Granted 7,900 shares of REGENXBIO Inc.13
- Jan 1, 2022Shares withheld for tax 1,332 shares at $32.70 of REGENXBIO Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARREGENXBIO Inc., General counsel
- 3
- 4SEC EDGARForm 4 filed Feb 3, 2026
- 5SEC EDGARForm 4 filed Jan 8, 2026
- 6SEC EDGARForm 4 filed Jan 6, 2026
- 7SEC EDGARForm 4 filed Aug 4, 2025
- 8SEC EDGARForm 4 filed Apr 4, 2025
- 9SEC EDGARForm 4 filed Jan 6, 2025
- 10SEC EDGARForm 4 filed Aug 5, 2024
- 11SEC EDGARForm 4 filed Jan 4, 2024
- 12SEC EDGARForm 4 filed Jan 5, 2023
- 13SEC EDGARForm 4 filed Jan 4, 2022